Skip to main content

Table 2 Problems related to medications detected by Self Audit: April 2016–December 2018

From: Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self Audit

Problem detected by Self Audit

Year 2016*

Apr 2016

Dec 2016

Variation

Percentage (%)

Duplicate therapies

46,242

41,589

 − 4653

 − 10

AEMPS safety alerts

13,521

6849

 − 6672

 − 49

Contraindications due to medical devices and/or clinical variables

37,359

37,421

62

0

Treatment duration

    

 Bisphosphonates ≥ 5 years

8246

7434

 − 812

 − 10%

 Double anti-aggregation ≥ 12 months

4805

4332

 − 473

 − 10%

Drugs advised against in geriatrics

88,393

83,638

 − 4755

 − 5

Combination of anticholinergic drugs

2913

2320

 − 593

 − 20

Avoidable medication

30,984

27,333

 − 3651

 − 12

Total number of problems detected

232,463

210,916

 − 21,547

 − 9

Problem detected by Self Audit

Year 2017

Apr 2017

Dec 2017

Variation

Percentage (%)

Duplicate therapies

65,679

59,536

 − 6143

 − 9

AEMPS safety alerts

11,212

9935

 − 1277

 − 11

Contraindications due to medical devices and/or clinical variables

44,687

44,000

 − 687

 − 2

Treatment duration

    

 Bisphosphonates ≥ 5 years

6386

4964

 − 1422

 − 22%

 Double anti-aggregation ≥ 12 months

4394

4508

114

3%

Drugs advised against in geriatrics

82,252

79,187

 − 3065

 − 4

Combination of anticholinergic drugs

2184

1819

 − 365

 − 17

Avoidable medication

26,986

23,907

 − 3079

 − 11

Total number of problems detected

243,780

227,856

 − 15,924

 − 7

Problem detected by Self Audit

Year 2018

Apr 2018

Dec 2018

Variation

Percentage (%)

Duplicate therapies

65,377

64,650

 − 727

 − 1

AEMPS safety alerts

7046

5441

 − 1605

 − 23

Contraindications due to medical devices and/or clinical variables

45,175

46,469

1294

3

Treatment duration

    

 Bisphosphonates ≥ 5 years

4552

4123

 − 429

 − 9%

 Double anti-aggregation ≥ 12 months

4631

4630

 − 1

0%

Drugs advised against in geriatrics

79,225

79,384

159

0

Combination of anticholinergic drugs

1854

1736

 − 118

 − 6

Avoidable medication

25,491

24,526

 − 965

 − 4

Total number of problems detected

233,351

230,959

 − 2392

 − 1

  1. *In the three years studied, April was taken as the baseline data because it is the time at which the definitions of the MRPs were updated according to the consensus of a group of experts, and it also is the month in which the incentive-based goals were proposed